Cash envelope banking-giving the control of spending back to the people
Valuation cap โ
$20.6M
As of Mar 2026 ยท from Reg CF Offering (2025) ยท a SAFE/note conversion ceiling, not a priced valuation
Total raised
$2,116,132
Across 2 rounds since 2021
Financials
FY2019โFY2024 ยท from SEC filings ยท hover any figure for its source
$0
โ$408K
2019
$17K
โ$637K
2020
$329K
$2.6M
2021
$2.0M
$236K
2022
$2.7M
โ$2.7M
2023
$1.8M
โ$2.6M
2024
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$16,667
$329,200
$2,024,642
$2,716,043
$1,769,074
Cost of goods sold
$0
$256
$3,699,237
$2,630,203
$1,853,090
$1,873,498
Gross margin
โ
98%
-1024%
-30%
32%
-6%
Net income
-$408,152
-$636,582
$2,599,237
$236,203
-$2,692,150
-$2,593,577
Taxes paid
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$462,145
$700,403
$42,656
$276,232
$344,941
$626,242
Accounts receivable
$0
$0
$6,528
$35,789
$87,487
$126,002
Total assets
$1,616,693
$3,227,193
$2,164,036
$2,686,709
$1,915,518
$1,775,621
Short-term debt
$57,769
$146,281
$345,390
$339,384
$808,366
$1,023,139
Long-term debt
$222,281
$298,954
$1,650,956
$4,024,124
$3,853,504
$4,232,908
Total liabilities
$280,050
$445,235
$1,996,346
$4,363,508
$4,661,870
$5,256,047
Other
Headcount
โ
15
โ
7
โ
4
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.